2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Hematologic Diseases
1
Bone Marrow Diseases
1
Interventions
Cisplatin
127
Carboplatin
127
Drug Therapy
116
Capecitabine
101
Bevacizumab
101
Oxaliplatin
99
Radiotherapy
97
tislelizumab
87
Paclitaxel
87
Cyclophosphamide
87
Gemcitabine
86
Specimen Handling
79
pembrolizumab
77
toripalimab
70
Magnetic Resonance Spectroscopy
66
Injections
65
Fluorouracil
63
sintilimab
58
Surgical Procedures, Operative
58
anlotinib
55
Docetaxel
53
130-nm albumin-bound paclitaxel
51
fludarabine
47
Pemetrexed
46
Standard of Care
45
Immune Checkpoint Inhibitors
45
Leucovorin
43
Blood Specimen Collection
43
Biopsy
43
venetoclax
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Bone Marrow Examination
×
Clear all
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled